Correlation Between Ashtead Group and Crispr Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ashtead Group and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ashtead Group and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ashtead Group Plc and Crispr Therapeutics AG, you can compare the effects of market volatilities on Ashtead Group and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ashtead Group with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ashtead Group and Crispr Therapeutics.

Diversification Opportunities for Ashtead Group and Crispr Therapeutics

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ashtead and Crispr is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Ashtead Group Plc and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Ashtead Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ashtead Group Plc are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Ashtead Group i.e., Ashtead Group and Crispr Therapeutics go up and down completely randomly.

Pair Corralation between Ashtead Group and Crispr Therapeutics

Assuming the 90 days horizon Ashtead Group Plc is expected to generate 0.79 times more return on investment than Crispr Therapeutics. However, Ashtead Group Plc is 1.26 times less risky than Crispr Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.03 per unit of risk. If you would invest  5,550  in Ashtead Group Plc on September 8, 2022 and sell it today you would earn a total of  500.00  from holding Ashtead Group Plc or generate 9.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Ashtead Group Plc  vs.  Crispr Therapeutics AG

 Performance (%) 
       Timeline  
Ashtead Group Plc 
Ashtead Performance
7 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Ashtead Group Plc are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Ashtead Group exhibited solid returns over the last few months and may actually be approaching a breakup point.

Ashtead Price Channel

Crispr Therapeutics 
Crispr Performance
0 of 100
Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2023. The recent disarray may also be a sign of long period up-swing for the firm insiders.

Crispr Price Channel

Ashtead Group and Crispr Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ashtead Group and Crispr Therapeutics

The main advantage of trading using opposite Ashtead Group and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ashtead Group position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.
Ashtead Group vs. United Rentals
Ashtead Group vs. Amerco
Ashtead Group vs. Willscot Mobile Mini
Ashtead Group vs. Goldman Sachs Group
The idea behind Ashtead Group Plc and Crispr Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Crispr Therapeutics vs. Merck Company
Crispr Therapeutics vs. Johnson Johnson
Crispr Therapeutics vs. Bondbloxx ETF Trust
Crispr Therapeutics vs. Fidelity MSCI Energy
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go